The Bariatric Surgery Appeal: How to Counter the Carrier's "Not Medically Necessary" for Weight-Loss Surgery

A 42-year-old elementary-school teacher in Nashville had completed five months and three weeks of the supervised diet program her surgeon's office had built around her carrier's policy bulletin. Her body mass index at intake had been 41.3. Her hemoglobin A1c was 7.9. Her sleep study, performed in October, had returned an apnea-hypopnea index of 38. The packet her surgeon's office sent to the carrier in February ran to 64 pages: the dietitian visit notes from each of the 24 monthly contacts, the psychological evaluation, the cardiology clearance, the pulmonology consult, the operative-plan letter, and the policy-citation cover sheet referencing the carrier's own published medical-necessity criteria for laparoscopic sleeve gastrectomy. The denial letter came back in nine business days. The reason given was that the supervised diet had not been six full consecutive months. The 24 monthly visits, counted on the carrier's reviewer's worksheet, spanned 23 weeks and 5 days. Two days short.

Bariatric surgery denials follow a small set of recurring patterns, and almost all of them turn on documentation rather than clinical merit. KFF analyses of large-employer commercial coverage have found that bariatric surgery is covered as a category by most large group plans, with denial driving on the application of specific criteria rather than on category exclusion. The American Society for Metabolic and Bariatric Surgery, in its 2022 joint clinical practice guidelines with the American Association of Clinical Endocrinology, reported that of patients who meet the modern indication thresholds and have a treating surgeon's recommendation, the share actually proceeding to surgery within 12 months is below 1 percent. The bottleneck is not clinical. It is administrative. The appeal that wins is the one that treats the denial as a documentation defect rather than as a disagreement about whether the surgery is appropriate.

What the carrier policy actually says

Almost every commercial carrier in the United States publishes a medical-policy bulletin on bariatric surgery, and the bulletins converge on a recognizable core. Coverage is offered for laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass, biliopancreatic diversion with duodenal switch, and adjustable gastric banding when each of the following is met: a body mass index of 40 or higher, or 35 or higher with at least one obesity-related comorbidity such as type 2 diabetes, obstructive sleep apnea, hypertension, hyperlipidemia, or non-alcoholic steatohepatitis; documentation of failed non-surgical weight management; a comprehensive multidisciplinary evaluation including dietitian, psychological, and medical clearance; and surgical performance at a designated Center of Excellence or by a surgeon meeting volume thresholds.

The disagreement almost never sits at the BMI line or at the comorbidity threshold. It sits at the supervised-diet requirement and at the surgical-center designation. Carriers most commonly require either six consecutive months of medically supervised weight management within the two years preceding the surgery request, with monthly documented visits, or a documented multi-year history of multiple non-surgical weight-loss attempts. The exact phrasing varies. Aetna's bulletin, Cigna's bulletin, BCBS plans' bulletins, and UnitedHealthcare's policy each use slightly different language for what looks superficially like the same requirement. A denial that cites "supervised diet" in the abstract often disregards a substantial portion of what the policy actually accepts.

The 2022 ASMBS guideline shift

In October 2022, the American Society for Metabolic and Bariatric Surgery and the International Federation for the Surgery of Obesity and Metabolic Disorders jointly published updated clinical indications for metabolic and bariatric surgery. The guideline expanded the population eligible for surgical consideration to include adults with a BMI of 30 to 34.9 who have type 2 diabetes, adults with BMI of 35 or higher with or without comorbidity, and adolescents meeting specific criteria. The guideline cited evidence accumulated since the 1991 NIH Consensus Statement, the document on which most carrier policies were originally built.

Most carrier bulletins have not been fully revised to reflect the 2022 guideline. The gap is the leverage point. A patient who falls within the expanded ASMBS indication but outside the older NIH threshold cannot rely on the carrier bulletin as written; the appeal asks the carrier to recognize the generally accepted standard of care has moved. Where state law incorporates "generally accepted standards" into the medical-necessity definition, the appeal anchors there. Where the contract simply requires "medical necessity" without further specification, the ASMBS guideline plus the supporting peer-reviewed evidence is what fills the term.

The six recurring denial patterns

The first pattern is the supervised-diet count. The carrier reviewer counts months differently than the patient's clinical team did. A denial that says "fewer than six consecutive months" should be cross-checked against the visit dates, the carrier's own definition of consecutive, and any documented allowable gap.

The second is comorbidity documentation. The carrier requires that comorbidities be "documented and refractory to medical management." A clinical note that lists diabetes as a problem is not the same as a note that records the medications tried, the A1c trajectory, and the endocrinologist's judgment that surgical intervention is now indicated.

The third is the psychological evaluation. Many denials cite an "inadequate psychological evaluation" without specifying what is missing. The ASMBS Standards Manual specifies the elements: mental health history, substance use screen, eating-disorder screen, cognitive assessment, motivation and adherence assessment, and a recommendation. A letter that contains all six elements is harder to deny on this ground.

The fourth is the Center of Excellence designation. Several carriers require performance at a Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) accredited center. A surgeon may be highly experienced but not credentialed at an MBSAQIP center; the appeal must either confirm the accreditation status or seek an in-network exception based on access.

The fifth is the procedure-specific exclusion. Some bulletins cover sleeve gastrectomy but not biliopancreatic diversion, or cover gastric bypass but not adjustable banding for new initiations. The denial of a specific procedure within a covered category is appealable on the basis that the procedure is the one the treating surgeon recommends for this patient.

The sixth is the revision-surgery denial. Coverage of a second bariatric procedure after weight regain or surgical complication runs on different criteria, often more restrictive. The 2022 ASMBS guideline addresses revision indications directly and is the principal support for these appeals.

Exhibit 1: BMI and comorbidity thresholds, NIH 1991 versus ASMBS 2022

The two reference frameworks differ in ways that matter for borderline patients. Most carrier bulletins still anchor to the 1991 thresholds; the 2022 guideline is what the appeal argues the carrier should apply.

| Indication framework | BMI 30-34.9 | BMI 35-39.9 | BMI 40+ | |---|---|---|---| | NIH 1991 Consensus | Not indicated | Indicated only with comorbidity | Indicated | | ASMBS 2022 (with IFSO) | Indicated if type 2 diabetes | Indicated regardless of comorbidity | Indicated | | Typical carrier bulletin (2025-2026) | Generally not covered | Covered with documented comorbidity | Covered | | Appeal posture for patient at this BMI | Cite ASMBS 2022 + diabetes evidence | Cite carrier bulletin + comorbidity documentation | Cite carrier bulletin + clinical readiness |

Action title for designer: "The medicine moved in 2022. Most carrier policies did not. The gap between the ASMBS guideline and the carrier bulletin is where many bariatric appeals are won."

Exhibit 2: The supervised-diet requirement, by carrier (illustrative)

Carrier bulletins vary in the precise count and in what counts. The table below illustrates patterns drawn from publicly posted medical-policy bulletins; specific contract language controls in each case.

| Carrier policy element | Typical requirement | Common appeal-relevant nuance | |---|---|---| | Length of supervised diet | 6 consecutive months within prior 2 years | "Consecutive" not always defined; brief gaps may be allowable | | Visit cadence | Monthly | Some bulletins accept biweekly or every-other-month equivalents | | Provider type | Physician-supervised | PA, NP, dietitian-supervised under physician oversight often accepted | | Documentation contents | Weight, dietary plan, exercise plan | Adherence notes and outcome metrics often missing in denials | | Alternative to 6-month diet | Multi-year history of attempts | Often invocable when contemporaneous visits are short | | Psychological evaluation | Required | ASMBS-element completeness is the key audit point | | Center designation | MBSAQIP-accredited preferred | In-network access exception available in many plans |

Action title for designer: "Most bariatric denials live in the supervised-diet column. The appeal that wins reads the policy precisely and disputes the carrier's count on its own terms."

Exhibit 3: The clinical-evidence stack for the medical-necessity appeal

The peer-reviewed and society-guideline evidence supporting bariatric surgery is robust enough that the medical-necessity argument is largely about correctly assembling and citing it.

| Evidence element | Source | Use in appeal | |---|---|---| | Updated indication thresholds | ASMBS / IFSO 2022 Joint Statement on Metabolic and Bariatric Surgery | Anchors the modern standard of care | | Comparative durability and outcomes | STAMPEDE 5-year trial (NEJM 2017) for diabetes resolution | Supports the comorbidity argument | | Long-term mortality benefit | Swedish Obese Subjects Study (long-term follow-up) | Supports necessity beyond weight metrics | | Cardiovascular event reduction | JAMA 2020, retrospective cohort analyses | Supports CV comorbidity-driven appeals | | Sleep apnea improvement | American Academy of Sleep Medicine guidance | Supports OSA comorbidity arguments | | NAFLD/NASH improvement | AASLD Practice Guidance on NAFLD | Supports hepatic comorbidity appeals | | Adolescent indication | ASMBS pediatric position statement | Required for pediatric appeals |

Action title for designer: "The evidence stack is durable, repeated, and society-endorsed. Most denials do not cite contrary evidence. They cite policy thresholds that the modern guideline has moved past."

What makes this difficult in practice

Bariatric appeals look mechanical on paper and turn on dozens of fine readings of the carrier's bulletin in practice. The mapped library Apellica has catalogued (more than two hundred carrier-by-denial-type cells, indexed at the bulletin level) each interpret "supervised diet" differently: monthly cadence at some carriers, biweekly equivalents at others, the dietitian-vs-physician supervisor question at a third group. The 2022 ASMBS guideline shift is the leverage point for borderline BMI patients, but the appeal that wins is the one that anchors the gap between the carrier's bulletin and current standard of care in the right state's medical-necessity definition.

The clinical-evidence stack runs to STAMPEDE, the Swedish Obese Subjects long-term follow-up, the comorbidity-specific society guidance (AASLD, AASM, the ADA Standards of Care), and the ASMBS pediatric position statement for adolescent cases. Compiling and citing it correctly is the work the surgeon's office often does not have time to do on appeal. The 30-day document-request right under 29 CFR 2560.503-1(h)(2)(iii) and 45 CFR 147.136(b)(2)(ii)(C) compels production of the operative bulletin version. Procedural exhaustion missteps foreclose external review.

The patient who has just completed five months and three weeks of a supervised diet, six clinical evaluations, and a cardiology clearance has been working on this surgery for a year. The appeal is the final step. It should not also be the one she has to learn on the fly.

A year of supervised work. Two days short on a worksheet. The clinical merits were not the question on the carrier's reviewer's desk.

The work the desk does that a patient cannot

Apellica's senior reviewers maintain the carrier-by-denial-type intelligence database, indexed at the bulletin level across more than two hundred cells, that tracks bariatric surgery bulletins at every major carrier (Aetna, Cigna, BCBS plans, UnitedHealthcare, Humana, regional Blues, Medicare Advantage, Medicaid managed care, TRICARE), including the supervised-diet count rules, the comorbidity documentation expectations, the psychological-evaluation element checklist, and the MBSAQIP-center exception pathway.

Same-day document-request letters go out with the correct CFR cite. Apellica's senior reviewers build the four-part evidence stack, plan-language citation, clinical facts mapped to the bulletin's criteria, peer-reviewed evidence including the ASMBS 2022 guideline and the STAMPEDE/SOS evidence base, regulatory hook, for every case. The supervised-diet count is cross-checked against the carrier's own definition of "consecutive" before any medical-necessity argument is mounted. A senior reviewer reads every appeal before it goes out.

Initial review is free. There is no upfront fee. Patients are not asked to pay anything until the carrier reverses the denial.

The procedural posture: deadlines, levels, parallel filings

Bariatric surgery denials follow the ordinary commercial-plan appeal track. Under ACA-regulated plans, the patient has 180 days from the denial date to file the internal appeal under 29 CFR 2560.503-1(h) for ERISA plans and under 45 CFR 147.136(b) for non-ERISA. After internal exhaustion, an external review is available under 45 CFR 147.136(d) through a state external-review process or, in states that have not built one, through the federal HHS-administered external review. The patient should preserve both the internal and external tracks rather than treating internal denial as the end.

If the patient is on Medicare Advantage, the deadline is 60 days under 42 CFR 422.582 and the case auto-forwards to an Independent Review Entity at Level 2. Bariatric surgery is generally covered under Medicare Part A and B when the criteria at NCD 100.1 are met; MA plans must apply the NCD under 42 CFR 422.101. A denial that contradicts the NCD is procedurally vulnerable.

If the patient is on TRICARE, the surgery is covered under specific criteria at 32 CFR 199.4(e)(15), and the appeal route runs through the TRICARE contractor and then the Defense Health Agency.

If the patient is on Medicaid, coverage and criteria vary by state. The state Medicaid manual is the controlling document, and the appeal runs through the state Medicaid fair-hearing process under 42 CFR 431.220.

State variation worth knowing

State law affects bariatric coverage in several discrete ways. A small number of states have mandated bariatric coverage for state-regulated plans or for state employee health plans. Several state Medicaid programs cover bariatric surgery; several others do not. The state insurance commissioner's external-review process becomes important when the internal appeal fails. The NAIC consumer site at content.naic.org/consumer.htm indexes the state contacts. Patients on self-funded ERISA plans do not get the benefit of state mandates, since ERISA preempts state insurance regulation for self-funded plans under 29 USC 1144.

The variation is concrete: a Texas state employee, a California Medicaid recipient, and a Florida self-funded ERISA participant who present with identical clinical facts will face different policy frameworks. The appeal should be built against the framework that actually controls the patient's coverage, not against a generic bariatric-coverage assumption.

Where to ask for help

The American Society for Metabolic and Bariatric Surgery, at asmbs.org, publishes both the 2022 indication guideline and a patient-facing resource library, and maintains the MBSAQIP center directory. The Obesity Action Coalition, at obesityaction.org, runs a patient-advocacy helpline and an appeal-letter resource library. The Obesity Medicine Association, at obesitymedicine.org, publishes provider-facing clinical guidance that supports comorbidity documentation. The state Department of Insurance complaint channels are indexed at content.naic.org/consumer.htm. For ERISA participants, the Department of Labor's Employee Benefits Security Administration is reachable at 1-866-444-3272 or askebsa.dol.gov. Apellica, at apellica.com, prepares evidence-based appeal letters for bariatric surgery denials in all 50 states with no upfront fee.

What to do if you have a bariatric denial right now

The clinical evidence in bariatric surgery is well established. Most denials are documentation defects, not medical-necessity disagreements. The clock starts when the carrier dated the denial; most patients calendar the wrong day.

Most patients leave coverage on the table because the supervised-diet-count cross-check, the bulletin-lag analysis, and the four-part appeal are more procedural work than they can take on after a year of preparation.

The Nashville teacher's appeal recharacterized the 24 monthly contacts under the carrier's own "monthly cadence equivalent" provision, attached the dietitian's contact log, and cited the ASMBS 2022 guideline against the carrier's six-month rule. The carrier reversed at the second-level internal appeal. Surgery was scheduled for the following month.

What Apellica does

Apellica prepares the evidence-based appeal letter for bariatric surgery denials in all 50 states, at every level of the internal and external appeal process. The patient reviews and approves every word before submission and authorizes carrier communications under a HIPAA-compliant Assignment of Benefits. We are not a law firm. We are not a medical provider. We are not an insurance carrier. We are an independent administrative service that turns a denied claim into a properly documented appeal letter.

Our model is $0 upfront and a flat fee on successful recovery. If the appeal does not reverse, the patient owes nothing for the preparation work. Coverage extends to all 50 states, every commercial carrier, Medicare Advantage, TRICARE, and Medicaid. A senior reviewer reads every case before it goes out.

About the author

Apellica is an independent appeal-preparation service for patients facing health-insurance denials. Mark Henderson is one of the senior reviewers on the desk. The firm operates from One World Trade Center in lower Manhattan and serves patients in all fifty states. Apellica is not a law firm and does not give legal advice. Reach the office at press@apellica.com, +1 (888) 777-6120, or apellica.com.

References

• American Society for Metabolic and Bariatric Surgery and International Federation for the Surgery of Obesity and Metabolic Disorders, 2022 ASMBS/IFSO Indications for Metabolic and Bariatric Surgery.
• American Association of Clinical Endocrinology and ASMBS, 2022 Clinical Practice Guidelines for Bariatric Procedures.
• National Institutes of Health, 1991 Consensus Development Conference Statement on Gastrointestinal Surgery for Severe Obesity.
• Schauer PR et al., STAMPEDE 5-year outcomes, New England Journal of Medicine, 2017.
• Sjostrom L et al., Swedish Obese Subjects Study long-term follow-up.
• American Association for the Study of Liver Diseases, Practice Guidance on NAFLD and NASH.
• American Academy of Sleep Medicine, Clinical Practice Guidelines on Obstructive Sleep Apnea.
• Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program, MBSAQIP Standards Manual.
• 29 CFR 2560.503-1. ERISA claims procedure.
• 45 CFR 147.136. Internal claims and appeals and external review.
• 42 CFR 422.582. Medicare Advantage reconsideration deadline.
• 42 CFR 422.101. Standards for MA contracts (NCD/LCD application).
• Medicare National Coverage Determination 100.1, Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity.
• 32 CFR 199.4(e)(15). TRICARE coverage of bariatric surgery.
• 42 CFR 431.220. Medicaid fair-hearing procedures.
• 29 USC 1144. ERISA preemption.
• Obesity Action Coalition. obesityaction.org.
• Obesity Medicine Association. obesitymedicine.org.
• NAIC Consumer Information Source. content.naic.org/consumer.htm.
• Department of Labor, Employee Benefits Security Administration. askebsa.dol.gov.